Hypercalcaemia of malignancy and Primary sequestrum

Summary:

Primary sequestrum is found among people with Hypercalcaemia of malignancy, especially for people who are female, 60+ old.

The study analyzes which people have Primary sequestrum with Hypercalcaemia of malignancy. It is created by eHealthMe based on reports of 53 people who have Hypercalcaemia of malignancy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypercalcaemia of malignancy?

Hypercalcaemia of malignancy (elevated calcium (ca+) level in the blood with cancer) is found to be associated with 87 drugs and 112 conditions by eHealthMe. Check the latest studies of Hypercalcaemia of malignancy.

What is Primary sequestrum?

Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone) is found to be associated with 598 drugs and 330 conditions by eHealthMe. Check the latest studies of Primary sequestrum.



On Jul, 30, 2026

53 people who have Hypercalcaemia Of Malignancy and Primary Sequestrum are studied.

Would you have Primary sequestrum when you have Hypercalcaemia of malignancy?

Gender of people who have Hypercalcaemia Of Malignancy and experienced Primary Sequestrum *:

  • female: 57.69 %
  • male: 42.31 %

Age of people who have Hypercalcaemia Of Malignancy and experienced Primary Sequestrum *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.76 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 16.67 %
  • 60+: 78.57 %

Common co-existing conditions for these people *:

  1. Metastases To Bone (cancer spreads to bone): 14 people, 26.42%
  2. Breast Cancer: 14 people, 26.42%
  3. Multiple Myeloma (cancer of the plasma cells): 12 people, 22.64%
  4. Depression: 6 people, 11.32%
  5. Cystitis Interstitial (unknown cause characterized by bladder pain): 6 people, 11.32%
  6. Breast Cancer Metastatic: 6 people, 11.32%
  7. Birth Control: 2 people, 3.77%
  8. Type 2 Diabetes: 1 person, 1.89%

Common drugs taken by these people *:

  1. Zometa: 53 people, 100.00%
  2. Lasix: 25 people, 47.17%
  3. Aredia: 25 people, 47.17%
  4. Taxotere: 23 people, 43.40%
  5. Carboplatin: 22 people, 41.51%
  6. Herceptin: 22 people, 41.51%
  7. Atenolol: 21 people, 39.62%
  8. Toprol-Xl: 20 people, 37.74%
  9. Aranesp: 20 people, 37.74%
  10. Klor-Con: 19 people, 35.85%

Common symptoms for these people *:

  1. Anaemia (lack of blood): 48 people, 90.57%
  2. Osteonecrosis Of Jaw (death of bone of jaw): 45 people, 84.91%
  3. Pain: 41 people, 77.36%
  4. Atherosclerosis (disorder of the arteries): 37 people, 69.81%
  5. Infection: 36 people, 67.92%
  6. Osteomyelitis (infection of bone): 34 people, 64.15%
  7. High Blood Pressure: 33 people, 62.26%
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 32 people, 60.38%
  9. Bone Disorder: 28 people, 52.83%
  10. Pain In Jaw: 28 people, 52.83%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Primary sequestrum?

- Check whether Primary sequestrum is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Primary sequestrum:

All the conditions that are associated with Primary sequestrum:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Primary sequestrum and Hypercalcaemia of malignancy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: